Guillermo Cuervo
Overview
Explore the profile of Guillermo Cuervo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
429
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cuervo G, Hernandez-Meneses M, de Alarcon A, Luque-Marquez R, Alonso-Socas M, Lopez-Lirola A, et al.
Infect Dis Ther
. 2025 Mar;
PMID: 40024946
Introduction: The POET trial demonstrated that moving from intravenous to oral antibiotics in stable patients with left-sided infective endocarditis (IE) was noninferior to fully parenteral treatment. However, it did not...
2.
Lapena P, Urra X, Llopis J, Hernandez-Meneses M, Cuervo G, Maisterra O, et al.
Clin Microbiol Infect
. 2025 Feb;
PMID: 39924109
Objectives: Acute ischaemic strokes (stroke) are frequent and severe extracardiac complications in infective endocarditis (IE). Because intravenous thrombolysis (i.v.-thrombolysis) is contraindicated, mechanical thrombectomy (thrombectomy) offers potential benefits. We aimed to...
3.
Marco D, Brey M, Anguera S, Pitart C, Grafia I, Bodro M, et al.
Crit Care
. 2025 Feb;
29(1):63.
PMID: 39910660
Background: Time to positivity (TTP) and differential TTP (DTP) emerge as diagnostic and prognostic tools for bloodstream infections (BSI) though specific cut-off values need to be determined for each pathogen....
4.
Garcia-Gonzalez J, Canas M, Cuervo G, Hernandez-Meneses M, Verdejo M, Bodro M, et al.
Microorganisms
. 2025 Jan;
12(12.
PMID: 39770714
(1) Background: Alternative antibiotics are needed to treat infective endocarditis (IE) caused by non-/non- enterococci; we aimed to assess the in vitro activity of ampicillin plus ceftriaxone (AMP + CTR)...
5.
Palom-Grau C, Cuervo G, Munoz P, Marin Arriaza M, Martinez-Selles M, Gonzalez-Ramallo V, et al.
J Am Coll Cardiol
. 2024 Nov;
85(4):305-318.
PMID: 39580721
Background: Coagulase-negative staphylococci (CoNS) are an increasingly common cause of infective endocarditis (IE) and lack recent data from large studies. Objectives: Our aim was to describe the epidemiology, clinical characteristics,...
6.
Escrihuela-Vidal F, Fernandez-Hidalgo N, Munoz P, Villamarin M, Jimenez Garcia N, Escudero E, et al.
J Antimicrob Chemother
. 2024 Oct;
79(12):3230-3235.
PMID: 39351977
Background: Infective endocarditis (IE) caused by viridans and gallolyticus group streptococci (VGS-GGS) resistant to penicillin (PEN-R; minimum inhibitory concentration ≥4 mg/L) is rare but poses therapeutic challenges. Objectives: To describe...
7.
Escrihuela-Vidal F, Chico C, Borjabad Gonzalez B, Vazquez Sanchez D, Lerida A, De Blas Escudero E, et al.
J Antimicrob Chemother
. 2024 Aug;
79(11):2858-2866.
PMID: 39212166
Background: Although a significant number of cases of Staphylococcus aureus bacteraemia (SAB) are managed at non-referral community hospitals, the impact of a bundle-of-care intervention in this setting has not yet...
8.
Lopera C, Monzo P, Aiello T, Chumbita M, Peyrony O, Gallardo-Pizarro A, et al.
Microbiol Spectr
. 2024 Aug;
12(10):e0296123.
PMID: 39194256
Importance: Multidrug-resistant (MDR) bacteria pose a global public health threat as they are more challenging to treat, and they are on the rise. Solid cancer patients are often immunocompromised due...
9.
Jeronimo A, Olmos C, Zulet P, Gomez-Ramirez D, Anguita M, Castillo J, et al.
Infection
. 2024 Jun;
52(6):2425-2434.
PMID: 38856806
Purpose: Most data regarding infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI) comes from TAVI registries, rather than IE dedicated cohorts. The objective of our study was to compare...
10.
Aranda-Domene R, Sandoval E, Cuervo G, Fernandez-Pittol M, Garcia de la Maria C, Quintana E
Indian J Thorac Cardiovasc Surg
. 2024 Jun;
40(Suppl 1):150-154.
PMID: 38827541
Supplementary Information: The online version contains supplementary material available at 10.1007/s12055-024-01727-4.